Background. Antimicrobial stewardship programs are nonexistent in most resource limited settings like Ethiopia. This has resulted in inappropriate use of antibiotics and widespread development of antibiotic resistance. Targeted initiatives surrounding antimicrobial use are needed to tackle this global health threat. Therefore, a program was established to generate data on antibiotic consumption, resistance, and facilitate appropriate use of antibiotics at an academic hospital in northwestern Ethiopia.
Methods. A committee was developed with a multidisciplinary team of clinicians, microbiologist, pharmacists and nurses. A baseline assessment of antibiotic use in the hospital was conducted through review of patient prescriptions and antibiotic inventory changes over time. To understand patterns, listed indication for use was recorded. Clinical audits, provider feedback mechanisms, and a quarterly antibiogram were also developed.
Results. Among 384 records of patients with infectious diseases, 250 adult and 134 pediatric cases were identified. Community acquired pneumonia (CAP) was the most common reason for use of antibiotics, accounting for 33.6% of adults and 22.2% of pediatric cases. Cephalosporins and penicillins were used in adults with CAP in 48.8% and 51.2% of cases, respectively, with or without macrolides or tetracycline. For severe CAP (30 cases), WHO or IDSA guideline concordance was identified as follows: appropriate antibiotic selection in 23 (76.6%), appropriate treatment duration in 15 (50.0%), and timely switch to oral therapy in 20 (66.7%) of the cases. The quarterly antibiogram included 516 bacterial isolates over one year. The most common organisms were Staphylococcus aureus and Escherichia coli, accounting for 34.7% and 16.8% isolates, respectively. The challenges faced in establishing the program were lack of electronic medical records for tracking antibiotic use and inconsistent supply of microbiologic reagents for microbial surveillance.
Conclusion. An effective antimicrobial stewardship program can be established in a resource limited setting with a committed team. Data generated by the program will be used to guide appropriate use of antibiotics and design interventions.
Disclosures. Background. ASPs optimize antibiotic use, achieve best outcomes, minimize adverse effects, reduce costs, and limit pressures contributing to the emergence AMR. SHEA, IDSA, and PIDS recommend mandatory implementation of ASP throughout healthcare institutions. The objective was to describe antimicrobial stewardship-related lessons learnt in light of interventions made during the first year of implementation of an ASP at the Princess Margaret Hospital in Nassau, Bahamas.
Methods. Prospective audit of antimicrobial use with feedback and intervention was the strategy employed by antimicrobial stewardship between November 2016 and September 2017. The clinical pharmacist monitored patients on adult medical, surgical wards, and critical care unit for the use of carbapenems, vancomycin, antipseudomonal cephalosporins, piperacillin-tazobactam, fluoroquinolones, intravenous fluconazole, amphotericin B, and acyclovir. Antimicrobial stewardship rounds were done by the ID physicians and clinical pharmacist in order to make recommendations to the clinical team. These included de-escalation, escalation of antimicrobial therapy, infectious diseases consultation recommendations, and pharmacokinetic dosing. Acceptability of prospective and feedback recommendations, time to intervention, and patients socio-demographics were also obtained.
Results.
Antimicrobial stewardship interventions included de-escalation 22 (41.5%), ID consultation 21 (39.6%), escalation 7 (13.2%), and pharmacokinetic dosing 3 (5.7%). 16 (73%) de-escalation of therapy was accepted and 6 (27%) not accepted. The mean number of days that antimicrobials were administered before intervention was 3 (range: 0-18 days).
Conclusion. An ASP is a feasible strategy to reduce emerging antimicrobial resistance in The Bahamas. Implementing an ASP in The Bahamas is practical and may result in significant de-escalation of antimicrobial therapy. The way forward is to formalize ASP into a sustainable, structured program within the institution.
Disclosures. All authors: No reported disclosures. Background. Surveillance and characterization of bacterial isolates are the preliminary approaches to optimize the use of antibiotics and guide both clinical and institutional decisions surrounding the perspicacious use of antibiotics. We sought to describe the local prevalence of bacterial resistance to direct our stewardship interventions.
Exploring Bacterial Resistance in
Methods. ResearchApproval was obtained from Ministry of Health, Sultanate of Oman. We surveyed all bacterial isolates collected by microbiology laboratory of Sohar Hospital (450-bed tertiary care facility serving patients of northern Oman) between January 1, 2016 to December 31, 2017. Acquired data included; patient demographics, requesting ward, relevant dates (admission, discharge, sample request and collection, result release), specimen type, isolate identification, and sensitivity. Samples from the same patient collected within less than a week with identical phenotype were excluded.
Results. Isolates (n = 15,733) were Gram-positive 29%, Gram-negative 67%, Candida species 23%, other fungi 0.3%, mycobacteria 0.4%. Of Gram-positive group, Staphylococcus aureus (MSSA 27% and MRSA16%), S. agalactiae 25%, coagulase negative staphylococci 12% and others (18 organisms) 19%. Vancomycin was active against 99% of tested isolates. Of Gram-negative group, E. coli 32%, P. aeruginosa 22%, K. pneumoniae 19%, A. baumannii 5%, P. mirabilis 4%, and others (57 organisms) 13%. Extended spectrum β-lactamase production was detected in 12% of cases, while phenotypic colorimetric testing revealed 4% carbapenemase production. Critical care units accommodated 70% of cases with carbapenem resistance infections consisting of 43% pneumonia, 27% blood stream infections, and 12% urinary tract infections.
Conclusion. Vancomycin resistance is limited, cefazolin, and other β-lactams are appropriate empirical agents for a wide range of cases, adequate vancomycin dosing and monitoring should be emphasized to hinder resistance development. Increasing number of carbapenem-resistant cases are being encountered, necessitating consideration of early detection and treatment, appropriate alternative agents and combinations, in addition to a multi-disciplinary approach to treat these recalcitrant infections.
Disclosures. All authors: No reported disclosures. Background. Antimicrobial resistance is a rising threat in developing nations. Establishing antimicrobial stewardship programs (ASP) in resource-limited settings may help curb the rise of antimicrobial resistance. Understanding local resistance patterns and antimicrobial usage may help define appropriate empiric treatment regimens and gaps for ASP development. There is a paucity of data on antimicrobial usage and local susceptibilities in the Dominican Republic (DR). As part of our antimicrobial stewardship initiative, we seek to define antimicrobial resistance and antimicrobial usage at Hospital General Plaza de la Salud (HGPS), a 200 bed teaching hospital in the DR.
Defining Antimicrobial Use and Resistance in a Teaching
Methods. This is a retrospective review of local susceptibility patterns and antimicrobial use. Antimicrobial susceptibility data for Gram-negative organisms was collected from 2014 to 2017. Antimicrobial use was collected from all inpatient units from January 1, 2017 to December 31, 2017. Defined daily doses (DDD) of antimicrobials used per 1,000 patient-days (DDD/1,000) was tabulated.
